메뉴 건너뛰기




Volumn 13, Issue 3, 2011, Pages 300-303

"Benign" myoclonic epilepsy of infancy as the initial presentation of glucose transporter-1 deficiency

Author keywords

Children; De vivo syndrome; Myoclonic epilepsy of infancy; Myoclonus; Seizure; SLC2A1

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; LAMOTRIGINE; TOPIRAMATE; VALPROIC ACID; DNA; SLC2A1 PROTEIN, HUMAN;

EID: 84856404355     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2011.0452     Document Type: Article
Times cited : (9)

References (13)
  • 1
    • 33645300746 scopus 로고    scopus 로고
    • Benign myoclonic epilepsy in infants: Electroclinical features and long-term follow-up of 34 patients
    • Auvin S, Pandit F, De Bellecize J, et al. Benign myoclonic epilepsy in infants: electroclinical features and long-term follow-up of 34 patients. Epilepsia 2006;47:387-93.
    • (2006) Epilepsia , vol.47 , pp. 387-393
    • Auvin, S.1    Pandit, F.2    De Bellecize, J.3
  • 3
    • 16544371492 scopus 로고    scopus 로고
    • Benign myoclonic epilepsy in infancy
    • Dravet C, Bureau M. Benign myoclonic epilepsy in infancy. Adv Neurol 2005;95:127-37.
    • (2005) Adv Neurol , vol.95 , pp. 127-137
    • Dravet, C.1    Bureau, M.2
  • 4
    • 33748676917 scopus 로고    scopus 로고
    • Report of the ILAE classification core group
    • DOI 10.1111/j.1528-1167.2006.00215.x
    • Engel J Jr. Report of the ILAE classification core group. Epilepsia 2006;47:1558-68. (Pubitemid 44393870)
    • (2006) Epilepsia , vol.47 , Issue.9 , pp. 1558-1568
    • Engel Jr., J.1
  • 5
    • 0037651879 scopus 로고    scopus 로고
    • Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome
    • DOI 10.1046/j.1528-1157.2003.05302.x
    • Leary LD, Wang D, Nordli DR Jr, Engelstad K, De Vivo DC. Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia 2003;44:701-7. (Pubitemid 36554639)
    • (2003) Epilepsia , vol.44 , Issue.5 , pp. 701-707
    • Leary, L.D.1    Wang, D.2    Nordli Jr., D.R.3    Engelstad, K.4    De Vivo, D.C.5
  • 6
    • 77950286198 scopus 로고    scopus 로고
    • Glucose transporter-1 deficiency syndrome: The expanding clinical and genetic spectrum of a treatable disorder
    • Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010;133:655-70.
    • (2010) Brain , vol.133 , pp. 655-670
    • Leen, W.G.1    Klepper, J.2    Verbeek, M.M.3
  • 8
    • 14644441679 scopus 로고    scopus 로고
    • Benign myoclonic epilepsy in infancy: Neuropsychological and behavioural outcome
    • DOI 10.1016/j.braindev.2004.04.011
    • Mangano S, Fontana A, Cusumano L. Benign myoclonic epilepsy in infancy: neuropsychological and behavioural outcome. Brain Dev 2005;27:218-23. (Pubitemid 40312033)
    • (2005) Brain and Development , vol.27 , Issue.SPEC. ISS. 3 , pp. 218-223
    • Mangano, S.1    Fontana, A.2    Cusumano, L.3
  • 9
    • 77955363549 scopus 로고    scopus 로고
    • Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency
    • Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 2010;75:432-40.
    • (2010) Neurology , vol.75 , pp. 432-440
    • Mullen, S.A.1    Suls, A.2    De Jonghe, P.3    Berkovic, S.F.4    Scheffer, I.E.5
  • 10
    • 12344321851 scopus 로고    scopus 로고
    • Predicting the three-dimensional structure of the human facilitative glucose transporter Glut1 by a novel evolutionary homology strategy: Insights on the molecular mechanism of substrate migration, and binding for glucose and inhibitory molecules
    • DOI 10.1529/biophysj.104.047886
    • Salas-Burgos A, Iserovich P, Zuniga F, Vera JC, Fischbarg J. Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules. Biophys J 2004;87:2990-9. (Pubitemid 40468559)
    • (2004) Biophysical Journal , vol.87 , Issue.5 , pp. 2990-2999
    • Salas-Burgos, A.1    Iserovich, P.2    Zuniga, F.3    Vera, J.C.4    Fischbarg, J.5
  • 11
    • 0041123574 scopus 로고    scopus 로고
    • Role of conserved arginine and glutamate residues on the cytosolic surface of glucose transporters for transporter function
    • DOI 10.1021/bi971173c
    • Schurmann A, Doege H, Ohnimus H, Monser V, Buchs A, Joost HG. Role of conserved arginine and glutamate residues on the cytosolic surface of glucose transporters for transporter function. Biochemistry 1997;36:12897-902. (Pubitemid 27465401)
    • (1997) Biochemistry , vol.36 , Issue.42 , pp. 12897-12902
    • Schurmann, A.1    Doege, H.2    Ohnimus, H.3    Monser, V.4    Buchs, A.5    Joost, H.-G.6
  • 12
    • 70350075265 scopus 로고    scopus 로고
    • Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1
    • Suls A, Mullen SA, Weber YG, et al. Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol 2009;66:415-9.
    • (2009) Ann Neurol , vol.66 , pp. 415-419
    • Suls, A.1    Mullen, S.A.2    Weber, Y.G.3
  • 13
    • 16544376130 scopus 로고    scopus 로고
    • Autosomal recessive benign myoclonic epilepsy of infancy
    • Zara F, De Falco FA. Autosomal recessive benign myoclonic epilepsy of infancy. Adv Neurol 2005;95:139-45.
    • (2005) Adv Neurol , vol.95 , pp. 139-145
    • Zara, F.1    De Falco, F.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.